BetterLife Pharma annual operating income
2018
2019
2023
2024
2025
2026
BetterLife Pharma Operating Income Growth & History (BETRF)
BetterLife Pharma's operating income was −$1.8M for fiscal 2026.
View full BetterLife Pharma company overviewBetterLife Pharma annual operating income history
| Fiscal year | Period ended | Operating income | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-01-31 | −$1.8M | $3.2M | — |
| 2025 | 2025-01-31 | −$5.0M | −$1.8M | — |
| 2024 | 2024-01-31 | −$3.2M | $6.2M | — |
| 2023 | 2023-01-31 | −$9.5M | — | — |
| 2019 | 2019-01-31 | −$6.8M | −$5.5M | — |
| 2018 | 2018-01-31 | −$1.4M | — | — |
BetterLife Pharma quarterly operating income
Q1.19
Q1.20
Q1.26
Q2.26
Q3.26
Q4.26
Q1.27
| Fiscal quarter | Period ended | Operating income | Change | YoY change |
|---|---|---|---|---|
| Q1 2027 | 2026-04-30 | −$561,395 | −$90,648 | — |
| Q4 2026 | 2026-01-31 | −$437,008 | — | — |
| Q3 2026 | 2025-10-31 | −$389,215 | — | — |
| Q2 2026 | 2025-07-31 | −$511,630 | — | — |
| Q1 2026 | 2025-04-30 | −$470,747 | — | — |
| Q1 2020 | 2019-04-30 | −$1.7M | $216,864 | — |
| Q1 2019 | 2018-04-30 | −$1.9M | — | — |
BetterLife Pharma operating income trends
Between the periods ended 2018-01-31 and 2026-01-31, BetterLife Pharma's operating income decreased from −$1.4M to −$1.8M, a change of −$453,703. The latest reported quarter, Q1 2027, shows −$561,395.
About the metric
What operating income means
Operating income is the profit or loss a company generates from its core business after cost of revenue and operating expenses, but before non-operating items such as interest and income taxes.
Calculation and source
SEC-reported operating income
TickerStat standardizes operating income reported in company SEC filings for aligned fiscal periods. It is not adjusted EBIT, an analyst estimate, or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review BetterLife Pharma source filings ↗